Literature DB >> 5449707

Detection of thrombopoietic activity in plasma by stimulation of suppressed thrombopoiesis.

D P Shreiner, J Levin.   

Abstract

Rabbits in which thrombocytosis had been produced by five daily transfusions of platelet concentrates had suppressed endogenous thrombopoiesis, as reflected by decreased incorporation of selenomethionine-(75)Se ((75)SeM) into the circulating platelet mass. Rabbits in which endogenous thrombopoiesis had been suppressed by transfusion-induced thrombocytosis were used to detect thrombopoietic activity in rabbit plasma. Thrombopoietic activity was demonstrated in the plasma of both normal and thrombocytopenic donor rabbits. A dose response relationship was observed between the incorporation of (75)SeM into platelets and the dose of plasma administered. Infusion of 20-150 ml of plasma from thrombocytopenic donors increased the incorporation of (75)SeM into platelets from 52 to 107% above control values. A dose response effect also was seen after infusion of normal plasma, but normal plasma produced less effect than comparable doses of plasma from thrombocytopenic donors. Rabbits with transfusion-induced thrombocytosis appear to be more sensitive assay animals for the detection of thrombopoietic activity than animals with normal platelet counts. Changes in the rate of appearance and levels of (75)SeM may primarily indicate changes in platelet protein or platelet size and are apparently more sensitive indicators of the state of thrombopoiesis than are alterations in the numbers of circulating platelets. The results strongly support the concept of a humoral agent, i.e. thrombopoietin, that acts on megakaryocytes to regulate platelet production.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5449707      PMCID: PMC322654          DOI: 10.1172/JCI106388

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Depression of the megakaryocyte-platelet system in rats by transfusion of platelets.

Authors:  T T Odell; C W Jackson; R S Reiter
Journal:  Acta Haematol       Date:  1967       Impact factor: 2.195

2.  Megakaryocyte size in thrombocytopenic and normal rats.

Authors:  S Ebbe; F Stohlman; J Overcash; J Donovan; D Howard
Journal:  Blood       Date:  1968-09       Impact factor: 22.113

3.  Response of mice with a decreased number of hematopoietic stem cells to doses of erythropoietin.

Authors:  T Kilbridge; W Fried
Journal:  J Lab Clin Med       Date:  1968-07

4.  Kinetics of thrombopoiesis.

Authors:  L A Harker
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

5.  Megakaryocyte maturation rate in thrombocytopenic rats.

Authors:  S Ebbe; F Stohlman; J Donovan; J Overcash
Journal:  Blood       Date:  1968-11       Impact factor: 22.113

6.  Effects of thrombocytopenia on megakaryocytopoiesis.

Authors:  T T Odell; C W Jackson; T J Friday; D E Charsha
Journal:  Br J Haematol       Date:  1969-07       Impact factor: 6.998

7.  Megakaryocytopoiesis in the rat with transfusion-induced thrombocytosis.

Authors:  S Ebbe; F Stohlman; J Donovan; D Howard
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

8.  Physiology of the regulation of platelet production.

Authors:  G De Gabriele; D G Penington
Journal:  Br J Haematol       Date:  1967-03       Impact factor: 6.998

9.  Platelet survival in rats with transfusion-induced thrombocytosis.

Authors:  S Ebbe; F Stohlman; J Donovan; D Howard
Journal:  J Lab Clin Med       Date:  1966-11

10.  Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  2 in total

Review 1.  Significance of polyploidy in megakaryocytes and other cells in health and tumor disease.

Authors:  M Winkelmann; P Pfitzer; W Schneider
Journal:  Klin Wochenschr       Date:  1987-12-01

2.  Regulation of human megakaryocytopoiesis. An in vito analysis.

Authors:  E M Mazur; R Hoffman; E Bruno
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.